สำนักงานคณะกรรมการกำกับหลักทรัพย์และตลาดหลักทรัพย์
Printed on 09 June 2026 08:03

Publication Document

Please enter search criteria
Document Type
Issuer / Underlying / Securities
Date From
To
 Reset

T.MAN PHARMACEUTICAL PUBLIC COMPANY LIMITED : TMAN

The Financial Statements which need to be revised ( 0 record(s) found)
Order DateCompany NameReviewed Financial Statement Details
Data not found
Finanacial Statements ( 18 record(s) found)
NameYearStatusTypePeriodAs OfDetails
T.Man Pharmaceutical Public Company Limited2026ReviewedConsolidatedQ131/03/2026
T.Man Pharmaceutical Public Company Limited2026ReviewedCompanyQ131/03/2026
T.Man Pharmaceutical Public Company Limited2025AuditedConsolidatedYear31/12/2025
T.Man Pharmaceutical Public Company Limited2025AuditedCompanyYear31/12/2025
T.Man Pharmaceutical Public Company Limited2025ReviewedConsolidatedQ330/09/2025
T.Man Pharmaceutical Public Company Limited2025ReviewedCompanyQ330/09/2025
T.Man Pharmaceutical Public Company Limited2025ReviewedConsolidatedQ230/06/2025
T.Man Pharmaceutical Public Company Limited2025ReviewedCompanyQ230/06/2025
T.Man Pharmaceutical Public Company Limited2025ReviewedConsolidatedQ131/03/2025
T.Man Pharmaceutical Public Company Limited2025ReviewedCompanyQ131/03/2025
Click here to display all results
Key Financial Ratio ( 0 record(s) found)
NameBusiness TypeTypePeriodYearAs OfDetails
Data not found
Management's Discussion and Analysis ( 10 record(s) found)
DateTimeHeadingLink
26/02/202607:25Management Discussion and Analysis Yearly Ending 31 Dec 2025
26/02/202506:30Management Discussion and Analysis Yearly Ending 31 Dec 2024 (Revised)
25/02/202521:26Management Discussion and Analysis Yearly Ending 31 Dec 2024
21/10/202408:22Management Discussion and Analysis Quarter 2 Ending 30 Jun 2024
21/10/202408:21Management Discussion and Analysis Yearly Ending 31 Dec 2023
14/05/202607:57Management Discussion and Analysis Quarter 1 Ending 31 Mar 2026
14/05/202506:30Management Discussion and Analysis Quarter 1 Ending 31 Mar 2025
13/08/202507:56Management Discussion and Analysis Quarter 2 Ending 30 Jun 2025
12/11/202506:47Management Discussion and Analysis Quarter 3 Ending 30 Sep 2025
12/11/202421:57Management Discussion and Analysis Quarter 3 Ending 30 Sep 2024
SEC has ordered to amend Finanacial Statements ( 0 record(s) found)
NameDescriptionDetails
Data not found
Last updated on 08 June 2026